Click on a filter below to refine your search. Remove a filter to broaden your search.
An increase in neurofilament light and a decrease in Aβ40 were associated with withdrawal of positive airway pressure for obstructive sleep apnea.
In Mendelian randomization analyses, 25(OH)D was associated with a risk for dementia but not stroke or neuroimaging outcomes.
However, patients who test positive for COVID-19 should still consider reaching out to their regular healthcare provider for Paxlovid first.
The association was most significant for those aged 65 years or older with a history of hypothyroidism who received medication.
The rates of severe disease were low for high-risk patients with mild-to-moderate COVID-19 treated with antispike monoclonal antibodies.
The ‘Test-to-Treat’ program is part of federal and city efforts to catch and treat infections early and be ready for new waves of the pandemic.
The director of the NIAID says the drug kept him out of the hospital, however.
Pfizer and Moderna are expected to start producing reformulated doses this summer.
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.
<1 percent of patients to whom Paxlovid was dispensed for mild-to-moderate COVID-19 had a hospitalization or emergency department encounter.